Purple Biotech Ltd.-ADRPPBT

13F holders, Q4 2025 (December 31)
18holders +5
5new positions
1sold out
1famous investor
$0.66avg. 13F price*

At the end of Q4 2025, 18 institutions reported holding Purple Biotech Ltd.-ADR (PPBT) in their 13F filings, up 5 from Q3 2025. 5 opened new positions and 1 sold out. The largest holders were Susquehanna International Group, LLP ($309K), Two Sigma Investments, LP ($102K) and SmartHarvest Portfolios, LLC ($31K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Purple Biotech Ltd.-ADR
CUSIP
74638P208
Latest filing quarter
Q4 2025

History

Number of 13F holders

05101520 Q3 2024: 10Q3 2024Q4 2024: 13Q4 2024Q1 2025: 8Q1 2025Q2 2025: 12Q2 2025Q3 2025: 13Q3 2025Q4 2025: 18Q4 2025

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions5$421K
Exits1$28K

All 13F filers, Q3 2025 → Q4 2025: 667,131 shares bought and 66,725 shares sold, net +600,406 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 18 holders

Susquehanna International Group, LLP 0.00% New 469,767 $309K
Two Sigma Investments, LP 0.00% New 155,353 $102K
SmartHarvest Portfolios, LLC 0.01% — 47,454 $31K
Citadel Advisors 0.00% Add +3.6% 42,737 $28K
BNP Paribas Financial Markets 0.00% Add +86.9% 21,075 $14K
Two Sigma Advisers, LP 0.00% New 14,700 $10K
Simplex Trading, LLC 0.00% Add +5779.6% 9,231 $6K
Rhumbline Advisers 0.00% Add +584.4% 7,392 $5K
Morgan Stanley 0.00% Reduce -45.0% 6,091 $4K
UBS Group AG 0.00% Reduce -47.9% 3,098 $2K
GAMMA Investing LLC 0.00% Reduce -77.6% 2,836 $2K
SBI Securities Co., Ltd. 0.00% Add +1500.0% 320 $210
Group One Trading LLC 0.00% New 294 $193
Northwestern Mutual Wealth Management Co. 0.00% No change 85 $56
Jones Financial Companies LLLP 0.00% New 50 $33
Global Retirement Partners, LLC 0.00% No change 16 $11
Tradewinds Capital Management, LLC 0.00% Reduce -90.0% 10 $7
Royal Bank of Canada 0.00% No change 107 $0

"% of holder's portfolio" is PPBT's weight in each manager's 13F, not the share of Purple Biotech Ltd.-ADR the manager owns.